Athanor Capital, LP Vertex Pharmaceuticals Inc Transaction History

Athanor Capital, LP

  • $24.6 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$207.01 - $276.09 $2.68 Million - $3.58 Million
-12,949 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$255.65 - $303.1 $2.77 Million - $3.29 Million
10,847 Added 516.03%
12,949 $3.52 Million
Q2 2020

Aug 13, 2020
BUY
$225.48 - $295.8 $473,958 - $621,771
2,102 New
2,102 $610,000

Others Institutions Holding VRTX

# of Institutions
1,716
Shares Held
225M
Call Options Held
1.19M
Put Options Held
1.56M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Athanor Capital, LP Portfolio

Follow Athanor Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athanor Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email